Quicklinks
Imagine. Activating your immune system to fight cancer.
It’s possible.
Qu Biologics is developing a new kind of cancer therapeutic. Our novel Site Specific Immunotherapies (SSIs) activate the body’s natural anti-cancer immune response. Qu Biologics’ SSIs have been tested in people with advanced cancer and the survival results are compelling.
Over the next year Qu Biologics will initiate new clinical trials in lung, colon, pancreatic and skin cancer. With strong preclinical and patient results, a robust patent portfolio and an experienced scientific team, Qu Biologics is poised to lead the next revolution in cancer immunotherapies.
These true life stories of remarkable recoveries are just the beginning of a potentially new, safe and effective approach to improve quality of life and survival of millions of cancer patients.